(Q83329973)
Statements
Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea (English)
Andrew Lewin
Timothy Bailey
Denise Chang
Titus Gylvin
Victor Roberts
NovoLog Mix-vs.-Exenatide Study Group
1 January 2009